X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
88
PharmaCompass offers a list of Tranexamic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tranexamic Acid manufacturer or Tranexamic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tranexamic Acid manufacturer or Tranexamic Acid supplier.
PharmaCompass also assists you with knowing the Tranexamic Acid API Price utilized in the formulation of products. Tranexamic Acid API Price is not always fixed or binding as the Tranexamic Acid Price is obtained through a variety of data sources. The Tranexamic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tranexamic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tranexamic Acid, including repackagers and relabelers. The FDA regulates Tranexamic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tranexamic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tranexamic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tranexamic Acid supplier is an individual or a company that provides Tranexamic Acid active pharmaceutical ingredient (API) or Tranexamic Acid finished formulations upon request. The Tranexamic Acid suppliers may include Tranexamic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Tranexamic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tranexamic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of Tranexamic Acid active pharmaceutical ingredient (API) in detail. Different forms of Tranexamic Acid DMFs exist exist since differing nations have different regulations, such as Tranexamic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tranexamic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. Tranexamic Acid USDMF includes data on Tranexamic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tranexamic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tranexamic Acid suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tranexamic Acid Drug Master File in Japan (Tranexamic Acid JDMF) empowers Tranexamic Acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tranexamic Acid JDMF during the approval evaluation for pharmaceutical products. At the time of Tranexamic Acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tranexamic Acid suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tranexamic Acid Drug Master File in Korea (Tranexamic Acid KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tranexamic Acid. The MFDS reviews the Tranexamic Acid KDMF as part of the drug registration process and uses the information provided in the Tranexamic Acid KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tranexamic Acid KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tranexamic Acid API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tranexamic Acid suppliers with KDMF on PharmaCompass.
A Tranexamic Acid CEP of the European Pharmacopoeia monograph is often referred to as a Tranexamic Acid Certificate of Suitability (COS). The purpose of a Tranexamic Acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tranexamic Acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tranexamic Acid to their clients by showing that a Tranexamic Acid CEP has been issued for it. The manufacturer submits a Tranexamic Acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tranexamic Acid CEP holder for the record. Additionally, the data presented in the Tranexamic Acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tranexamic Acid DMF.
A Tranexamic Acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tranexamic Acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tranexamic Acid suppliers with CEP (COS) on PharmaCompass.
A Tranexamic Acid written confirmation (Tranexamic Acid WC) is an official document issued by a regulatory agency to a Tranexamic Acid manufacturer, verifying that the manufacturing facility of a Tranexamic Acid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tranexamic Acid APIs or Tranexamic Acid finished pharmaceutical products to another nation, regulatory agencies frequently require a Tranexamic Acid WC (written confirmation) as part of the regulatory process.
click here to find a list of Tranexamic Acid suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tranexamic Acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tranexamic Acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tranexamic Acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tranexamic Acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tranexamic Acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tranexamic Acid suppliers with NDC on PharmaCompass.
Tranexamic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tranexamic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tranexamic Acid GMP manufacturer or Tranexamic Acid GMP API supplier for your needs.
A Tranexamic Acid CoA (Certificate of Analysis) is a formal document that attests to Tranexamic Acid's compliance with Tranexamic Acid specifications and serves as a tool for batch-level quality control.
Tranexamic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Tranexamic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tranexamic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Tranexamic Acid EP), Tranexamic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tranexamic Acid USP).
Market Place
